Granite Investment Partners, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granite Investment Partners, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$13,497,000
-9.1%
338,701
-8.7%
0.85%
-7.7%
Q3 2017$14,846,000
-28.7%
371,154
-23.2%
0.92%
-34.2%
Q2 2017$20,816,000
+41.3%
482,962
+2.6%
1.40%
+39.0%
Q1 2017$14,736,000
+36.7%
470,799
+10.3%
1.01%
+27.1%
Q4 2016$10,778,000
-1.1%
426,832
-3.2%
0.79%
-2.3%
Q3 2016$10,900,000
+1.5%
440,771
-16.4%
0.81%
-3.9%
Q2 2016$10,738,000
+107.4%
527,170
+55.3%
0.85%
+80.4%
Q1 2016$5,177,000
+478.4%
339,500
+409.9%
0.47%
+479.0%
Q4 2015$895,000
-13.4%
66,577
-9.7%
0.08%
-18.2%
Q3 2015$1,034,000
-43.2%
73,734
-31.3%
0.10%
-41.1%
Q2 2015$1,822,000
+12.1%
107,307
-20.2%
0.17%
+20.0%
Q1 2015$1,625,000
+97.4%
134,396
+35.5%
0.14%
+50.5%
Q4 2014$823,000
+131.8%
99,166
+142.5%
0.09%
+89.8%
Q3 2014$355,000
-18.6%
40,891
+2.7%
0.05%
-21.0%
Q2 2014$436,000
+24.2%
39,806
+1.4%
0.06%
+12.7%
Q1 2014$351,00039,2670.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders